STEOVESS alendronic acid (as sodium) 70mg effervescent tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

alendronate sodium, Quantity: 91.37 mg (Equivalent: alendronic acid, Qty 70 mg)

Commercializzato da:

Pharmbio Pty Ltd

INN (Nome Internazionale):

alendronate sodium

Forma farmaceutica:

Tablet, effervescent

Composizione:

Excipient Ingredients: monosodium dihydrogen citrate; citric acid; sodium bicarbonate; sodium carbonate; acesulfame potassium; sucralose; Flavour

Via di somministrazione:

Oral

Confezione:

4, 1, 2

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Steovess is indicated for the treatment of osteoporosis. Prior to treatment, osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by the presence of osteoporotic fracture

Dettagli prodotto:

Visual Identification: White to off-white round, flat tablet with bevelled edges; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2012-06-18